Á¦ ¸ñ    imgNCWoUZNH
ÀÌ ¸§    Sergio ³¯ Â¥    2018/06/28 Á¶ ȸ    2


It's OK anabeta elite buy Shares in Ranbaxy, which is majority-owned by Daiichi Sankyo, had been rising steadily since the news of that fine but this latest FDA ban has scuppered the stock, pushing it down over 30%. These means that the three plants in India the company uses to manufacture treatments for the USA cannot ship product to a market that makes up over 40% of Ranbaxy sales.